← Leaderboards
Andrew T Parsa
University Of California San Francisco
$4,652,464
Attributed
$4,652,464
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $658.1K · FY2005–17$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$4,652,464 · 4
By mechanism
P50$3,213,876 · 2
K08$807,030 · 1
R01$631,558 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- John K. Wiencke$22,119,904
- Margaret R. Wrensch$18,687,663
- Mitchel S. Berger$12,317,215
- Abul K. Abbas$11,304,463
- Charles James Ryan$1,624,267
Others in their field
Top investigators on “Glioma”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$158,144,386
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,436,447
- David Heimbrook · Leidos Biomedical Research, Inc.$56,561,099
- Gregory H Reaman · National Childhood Cancer Foundation$49,046,612
- Melissa L Bondy · Stanford University$36,047,564
- Brad H. Pollock · University Of Florida$28,646,726
Research focus
GliomaT-LymphocyteImmunotherapyResponseFlow CytometryCellsMediatingImmunosuppressive AgentsCoculture TechniquesPathway InteractionsCd8b1 GeneApoptosisHomologous GeneImmune ResponseSpecimenAntibodiesTumorPeripheralProteinsGlioblastomaAutologousInfiltrationVaccinationCytokine
Grant awards (18)
OVERCOMING LOCAL AND PERIPHERAL IMMUNE SUPPRESSION IN GLIOMA TO FACILITATE EFFEC$361,125
P50 · FY2017 · CA · contact PI
OVERCOMING LOCAL AND PERIPHERAL IMMUNE SUPPRESSION IN GLIOMA TO FACILITATE EFFEC$296,700
P50 · FY2016 · CA · contact PI
OVERCOMING LOCAL AND PERIPHERAL IMMUNE SUPPRESSION IN GLIOMA TO FACILITATE EFFEC$319,450
P50 · FY2015 · CA · contact PI
OVERCOMING LOCAL AND PERIPHERAL IMMUNE SUPPRESSION IN GLIOMA TO FACILITATE EFFEC$325,621
P50 · FY2014 · CA · contact PI
B7H1 Mediated Immunosuppression in Glioma$310,970
R01 · FY2014 · CA · contact PI
OVERCOMING LOCAL AND PERIPHERAL IMMUNE SUPPRESSION IN GLIOMA TO FACILITATE EFFEC$337,506
P50 · FY2013 · CA · contact PI
B7H1 Mediated Immunosuppression in Glioma$320,588
R01 · FY2013 · CA · contact PI
Heat Shock Protein Vaccine Dev: Glioma immunoresistance and PI(3)K/Akt/mTOR pathw$59,989
P50 · FY2012 · CA · contact PI
Heat Shock Protein Vaccine Dev: Glioma immunoresistance and PI(3)K/Akt/mTOR pathw$295,601
P50 · FY2011 · CA · contact PI
Heat Shock Protein Vaccine Dev: Glioma immunoresistance and PI(3)K/Akt/mTOR pathw$307,244
P50 · FY2010 · CA · contact PI
Heat Shock Protein Vaccine Dev: Glioma immunoresistance and PI(3)K/Akt/mTOR pathw$306,425
P50 · FY2009 · CA · contact PI
Heat Shock Protein Vaccine Dev: Glioma immunoresistance and PI(3)K/Akt/mTOR pathw$307,246
P50 · FY2008 · CA · contact PI
Heat Shock Protein Vaccine Dev: Glioma immunoresistance and PI(3)K/Akt/mTOR pathw$296,969
P50 · FY2007 · CA · contact PI
Antigen specific modeling of glioma immunotherapy$161,406
K08 · FY2007 · NS · contact PI
Antigen specific modeling of glioma immunotherapy$161,406
K08 · FY2006 · NS · contact PI
Antigen specific modeling of glioma immunotherapy$161,406
K08 · FY2005 · NS
Antigen specific modeling of glioma immunotherapy$161,406
K08 · FY2004 · NS
Antigen specific modeling of glioma immunotherapy$161,406
K08 · FY2003 · NS